Meiji Seika Sets Up New CNS Sales Facilities In Tokyo, Osaka, Nagoya
This article was originally published in PharmAsia News
Executive Summary
MeijiSeika will establish seven new facilities in Tokyo, Osaka, and Nagoya, which will all specialize in central nervous system sales.
You may also be interested in...
J&J Quickly Advances BCMA-Targeting CAR-T As JNJ-4528 Shows 100% Response
Phase Ib data at ASH look competitive with new pivotal trial results for Bristol/bluebird’s leading BCMA CAR-T bb2121. The Phase II portion of the CARTITUDE-1 study for JNJ-4528 is fully enrolled.
Chiesi Files India Legal Action Against Cipla Over Respiratory Therapy Patent
Fragrance Creators Association Readies New Consumer Website To Cap ‘Year For The Public’
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: